Key result
Percutaneous treatment with the Amplatzer Vascular Plug III device was utilized as an alternative to surgery for an 81-year-old patient with symptomatic aortic paravalvular leak.
Case Report (n=1)
Percutaneous closure using an Amplatzer Vascular Plug III device represents a potential alternative to repeat surgery for high-risk patients with symptomatic prosthetic paravalvular leak.
May relieve symptoms in high-risk paravalvular leak patients; leaves open need for prospective trials.
A significant prosthetic paravalvular leak is an uncommon and severe postsurgical complication correlated to the occurrence of congestive heart failure and hemolytic anemia. Percutaneous treatment has become an attractive and effective proposal to relieve symptoms and reduce complications in patients whose high rate of morbidity/mortality precludes a new surgery. This is the case of an 81-year-old patient with a history of biological aortic valve replacement seeking medical help due to heart failure and hemolytic anemia, with a prosthetic paravalvular regurgitation jet and high surgical mortality according to EuroSCORE II.
No takes yet. Share an insight, caveat, or question.
Baztarrica et al. (2018) conducted a case report in Symptomatic Aortic Paravalvular Leak (n=1). Percutaneous treatment with Amplatzer Vascular Plug III Device was evaluated. Percutaneous treatment with the Amplatzer Vascular Plug III device was utilized as an alternative to surgery for an 81-year-old patient with symptomatic aortic paravalvular leak.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: